This GitLab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday – GitLab (NASDAQ:GTLB), Amrize (NYSE:AMRZ)

Jul 15, 2025
this-gitlab-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-tuesday-–-gitlab-(nasdaq:gtlb),-amrize-(nyse:amrz)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Piper Sandler analyst Derek Podhaizer initiated coverage on Select Water Solutions, Inc. WTTR with an Overweight rating and announced a price target of $15. Select Water Solutions shares closed at $9.28 on Monday. See how other analysts view this stock.
  • JP Morgan analyst Adrian Huerta initiated coverage on Amrize Ltd AMRZ with an Overweight rating and announced a price target of $57. Amrize shares closed at $50.57 on Monday. See how other analysts view this stock.
  • Rosenblatt analyst Blair Abernethy initiated coverage on GitLab Inc. GTLB with a Buy rating and announced a price target of $58. GitLab shares closed at $42.57 on Monday. See how other analysts view this stock.
  • Barclays analyst Julian Mitchell initiated coverage on Ralliant Corporation RAL with an Overweight rating and announced a price target of $60. Ralliant shares closed at $47.36 on Monday. See how other analysts view this stock.
  • Goldman Sachs analyst Andrea Newkirk initiated coverage on Revolution Medicines, Inc. RVMD with a Buy rating and announced a price target of $65. Revolution Medicines shares closed at $38.37 on Monday. See how other analysts view this stock.

Considering buying GTLB stock? Here’s what analysts think:

Trending Investment Opportunities

Read This Next:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Leave a comment